181 related articles for article (PubMed ID: 6807593)
1. The effect of indomethacin on para-articular ectopic ossification following total hip arthroplasty.
Ritter MA; Gioe TJ
Clin Orthop Relat Res; 1982 Jul; (167):113-7. PubMed ID: 6807593
[TBL] [Abstract][Full Text] [Related]
2. [Indomethacin in the prevention of para-articular ossification following total hip endoprosthesis].
Hochheim B; Wünsche F
Beitr Orthop Traumatol; 1990 Jun; 37(6):330-4. PubMed ID: 2117436
[TBL] [Abstract][Full Text] [Related]
3. Short term prophylaxis against heterotopic bone after cementless hip replacement.
Wurnig C; Auersperg V; Boehler N; Steindl M; Kiss H; Zweymuller K; Kotz R
Clin Orthop Relat Res; 1997 Jan; (334):175-83. PubMed ID: 9005911
[TBL] [Abstract][Full Text] [Related]
4. [Postoperative radiotherapy in the prevention of heterotopic ossification after endoprosthetic hip joint replacement].
Heyd R; Strassmann G; Kirchner J; Schopohl B; Böttcher HD
Strahlenther Onkol; 1996 Oct; 172(10):543-52. PubMed ID: 8966671
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic indomethacin for the prevention of heterotopic bone formation following total hip arthroplasty.
Ritter MA; Sieber JM
Clin Orthop Relat Res; 1985 Jun; (196):217-25. PubMed ID: 3995821
[TBL] [Abstract][Full Text] [Related]
6. [Factors affecting the development of para-articular ossification in total hip replacement].
Landor I; Vavrík P; Havelka S; Jahoda D
Acta Chir Orthop Traumatol Cech; 1993; 60(2):76-80. PubMed ID: 8342379
[TBL] [Abstract][Full Text] [Related]
7. Single dose 6 Gy prophylaxis for heterotopic ossification after total hip arthroplasty.
Fingeroth RJ; Ahmed AQ
Clin Orthop Relat Res; 1995 Aug; (317):131-40. PubMed ID: 7671467
[TBL] [Abstract][Full Text] [Related]
8. [Para-articular (ectopic or heterotopic) ossification following total hip prosthesis].
Rudicel S
Orthopade; 1985 Feb; 14(1):54-7. PubMed ID: 3921900
[No Abstract] [Full Text] [Related]
9. Prevention of heterotopic ossification in cases of hypertrophic osteoarthritis submitted to total hip arthroplasty. Etidronate or Indomethacin?
Vasileiadis GI; Sakellariou VI; Kelekis A; Galanos A; Soucacos PN; Papagelopoulos PJ; Babis GC
J Musculoskelet Neuronal Interact; 2010 Jun; 10(2):159-65. PubMed ID: 20516633
[TBL] [Abstract][Full Text] [Related]
10. Heterotopic ossification prophylaxis following operative treatment of acetabular fracture.
Johnson EE; Kay RM; Dorey FJ
Clin Orthop Relat Res; 1994 Aug; (305):88-95. PubMed ID: 8050251
[TBL] [Abstract][Full Text] [Related]
11. The influence of heterotopic ossification on functional status of hip joint following total hip arthroplasty.
Pohl F; Seufert J; Tauscher A; Lehmann H; Springorum HW; Flentje M; Koelbl O
Strahlenther Onkol; 2005 Aug; 181(8):529-33. PubMed ID: 16044221
[TBL] [Abstract][Full Text] [Related]
12. Heterotopic bone formation in total hip arthroplasty: predisposing factors, classification and the significance for clinical outcome.
Schara K; Herman S
Acta Chir Orthop Traumatol Cech; 2001; 68(2):105-8. PubMed ID: 11706718
[TBL] [Abstract][Full Text] [Related]
13. Indomethacin for prevention of ectopic ossification after hip arthroplasty.
Kjaersgaard-Andersen P; Schmidt SA
Acta Orthop Scand; 1986 Feb; 57(1):12-4. PubMed ID: 3083642
[TBL] [Abstract][Full Text] [Related]
14. Clinical effect of etidronate disodium (EHDP) on heterotopic ossification following total hip arthroplasty.
Yutani Y; Ohashi H; Nishimura N; Yamano Y
Osaka City Med J; 1995 Dec; 41(2):63-73. PubMed ID: 8778647
[TBL] [Abstract][Full Text] [Related]
15. Erythrocyte sedimentation rate and heterotopic bone formation after cemented total hip arthroplasty.
Kjaersgaard-Andersen P; Schmidt SA; Pedersen NW; Kristensen SS; Pedersen P
Clin Orthop Relat Res; 1989 Nov; (248):189-94. PubMed ID: 2509120
[TBL] [Abstract][Full Text] [Related]
16. Selective COX-2 inhibitor versus indomethacin for the prevention of heterotopic ossification after hip replacement: a double-blind randomized trial of 100 patients with 1-year follow-up.
Grohs JG; Schmidt M; Wanivenhaus A
Acta Orthop; 2007 Feb; 78(1):95-8. PubMed ID: 17453399
[TBL] [Abstract][Full Text] [Related]
17. [Prevention of heterotopic ossification after THA with indomethacin: analysis of risk factors].
Zehetgruber H; Grübl A; Goll A; Schwameis E; Wurnig C; Giurea A
Z Orthop Ihre Grenzgeb; 2005; 143(6):631-7. PubMed ID: 16380894
[TBL] [Abstract][Full Text] [Related]
18. Naproxen for 8 days can prevent heterotopic ossification after hip arthroplasty.
Gebuhr P; Wilbek H; Soelberg M
Clin Orthop Relat Res; 1995 May; (314):166-9. PubMed ID: 7634631
[TBL] [Abstract][Full Text] [Related]
19. Stable bony integration with and without short-term indomethacin prophylaxis. A 5-year follow-up.
Trnka HJ; Zenz P; Zembsch A; Easley M; Ritschl P; Salzer M
Arch Orthop Trauma Surg; 1999; 119(7-8):456-60. PubMed ID: 10613239
[TBL] [Abstract][Full Text] [Related]
20. Similar effects of rofecoxib and indomethacin on the incidence of heterotopic ossification after hip arthroplasty.
van der Heide HJ; Rijnberg WJ; Van Sorge A; Van Kampen A; Schreurs BW
Acta Orthop; 2007 Feb; 78(1):90-4. PubMed ID: 17453398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
